Laparoscopic ovarian drilling in the treatment of polycystic ovary syndrome: How many punctures per ovary are needed to improve the reproductive outcome?
Article first published online: 10 MAR 2005
DOI: 10.1111/j.1447-0756.2005.00255.x
Additional Information
How to Cite
Malkawi, H. Y. and Qublan, H. S. (2005), Laparoscopic ovarian drilling in the treatment of polycystic ovary syndrome: How many punctures per ovary are needed to improve the reproductive outcome?. Journal of Obstetrics and Gynaecology Research, 31: 115–119. doi: 10.1111/j.1447-0756.2005.00255.x
Publication History
- Issue published online: 10 MAR 2005
- Article first published online: 10 MAR 2005
- Received: May 17 2004. Accepted: November 15 2004.
- Abstract
- Article
- References
- Cited By
Keywords:
- clomiphene citrate resistance;
- laparoscopic ovarian drilling;
- polycystic ovary syndrome
Abstract
Aim: To evaluate the biochemical, clinical and reproductive results after laparoscopic ovarian drilling that carried out a different number of punctures in the ovaries.
Methods: Sixty-three clomiphene-citrate-resistant women with polycystic ovary syndrome (PCOS) underwent laparoscopic ovarian drilling using insulated needle cautery. Patients were allocated to two groups: group I (n = 26) had five punctures per ovary, and group II (n = 37) had 10 punctures per ovary. Biochemical and clinical data, before and after the procedure along with the reproductive outcome, were compared between the two groups.
Results: There were no significant differences in terms of body mass index, and insulin and glucose levels before and after the procedure between the two groups. Androgen levels and luteinizing hormone concentrations showed a statistically significant decrease after the treatment. The clinical and reproductive outcome, including menses cyclicity, ovulation, and pregnancy rates were similar in both groups.
Conclusion: Laparoscopic ovarian drilling is an effective treatment in clomiphene-citrate-resistant women with PCOS. Five, instead of ≥10, punctures per ovary are sufficient to ameliorate the hyperandrogenic status in these women, improving their clinical and reproductive outcome.

1447-0756/asset/JOG_left.gif?v=1&s=5077c1b670807015301d074d6f555f0c7129ba8c)
1447-0756/asset/JOG_right.gif?v=1&s=4a3d984eea92b5fe8083ee1c0f5e1f037893c769)
